Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Zinbryta (daclizumab)
i
Other names:
BIIB019, DAC-HYP, R-35, RO 247375, DAC HYP
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
AbbVie, Biogen
Drug class:
CD25 inhibitor, IL-2R antagonist
Related drugs:
‹
ALD2510 (0)
ANV419 (0)
INV322 (0)
basiliximab (0)
AU-007 (0)
RG6292 (0)
EQ101 (0)
LMB-2 (0)
ALD2510 (0)
ANV419 (0)
INV322 (0)
basiliximab (0)
AU-007 (0)
RG6292 (0)
EQ101 (0)
LMB-2 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login